Clinical Trials Logo

Clinical Trial Summary

The study aims to assess the presence of fetal cardiac remodeling and dysfunction in singleton pregnancies conceived by assisted reproductive technology (Biopsied and Non-Biopsied ICSI) as compared with those conceived spontaneously (SC).


Clinical Trial Description

For gynecologists, reaching a conclusion about fetal cardiac remodeling and dysfunction in singleton pregnancies conceived by assisted reproductive technology (Biopsied and Non-Biopsied ICSI) or conceived spontaneously (SC) that would influence the clinical decision and best practice. Besides enriching the clinical evidence in fetal cardiac remodeling and dysfunction. For society, the conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for fetal cardiac remodeling and dysfunction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05172336
Study type Observational
Source Wael Elbanna Clinic
Contact Wael El Banna, Consultant
Phone 01227760402
Email waelelbanna@drwaelelbanna.com
Status Recruiting
Phase
Start date August 28, 2021
Completion date December 30, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03536000 - Fetal Cardiac Function Evaluation With aCMQ-Strain Fetal (STRAIN)
Recruiting NCT05066399 - Fetal Cardiac Magnetic Resonance in Detection of CHD
Not yet recruiting NCT05877131 - Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions Phase 4
Completed NCT05737043 - Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios N/A
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Recruiting NCT05386173 - Effect of Fetal Aortic Valvuloplasty on Outcomes